DUK vs NVCT · P/E 19, rev $31.74B vs $304.5M cap
Duke Energy Corporation (DUK) versus Nuvectis Pharma Inc (NVCT) — a side-by-side from cached financials, not a winner call.
Duke Energy Corporation (DUK) is a utilities - regulated electric company listed on NYSE.
Nuvectis Pharma Inc (NVCT) is a biotechnology company listed on NASDAQ.
Latest reported DUK revenue for 2025-12-31 was $31.74B. Net income was $4.97B. Revenue was up 5.6% from 2024-12-31 to 2025-12-31. DUK currently screens at market cap $96.46B and trailing P/E 19.0.
NVCT does not have a complete income-statement cache yet.
DUK currently screens at market cap $96.46B and trailing P/E 19.0. NVCT currently screens at market cap $304.5M.
Not investment advice. Open the DUK and NVCT stock pages for the full models.
Not investment advice.